CVS Test 2 February 2015

15 Questions | Total Attempts: 56

SettingsSettingsSettings
Please wait...
CVS Test 2 February 2015

Questions and Answers
  • 1. 
    This question refer to the article“Bedtime dosing of nifedipine GITS inhypertensive patients”:Oedema was found to be more likely tooccur in patients who were older andheavier.
    • A. 

      True

    • B. 

      False

  • 2. 
    This question refer to the article“Gliclazide Modified Release: Its place inthe therapeutic armamentarium”:An analysis of the United KingdomProspective Diabetes Study showedthat, in the long term, monotherapy withmetformin is more effective in achievingglycaemic targets in overweight patientsthan sulfonylureas.
    • A. 

      True

    • B. 

      False

  • 3. 
    This question refer to the article“Gliclazide Modified Release: Its place inthe therapeutic armamentarium”:Gliclazide modified release has beenshown to assist obese patients in avoidingfurther weight gain during treatment
    • A. 

      True

    • B. 

      False

  • 4. 
    This question refer to the article “Areview of perindopril arginine and itsbenefits”:Perindoprilat is a metabolite ofperindopril.
    • A. 

      True

    • B. 

      False

  • 5. 
    This question refer to the article “Areview of perindopril arginine and itsbenefits”:Perindopril arginine has an increasedshelf life compared to perindopril tertbutylamineand is suitable for use inclimatic zones III and IV
    • A. 

      True

    • B. 

      False

  • 6. 
    This question refer to the article“Gliclazide Modified Release: Its place inthe therapeutic armamentarium”:Hypertension and dyslipidaemiaare implicated as risk factors fordiabetic microangiopathy only, whilemacroangiopathy is not affected.
    • A. 

      True

    • B. 

      False

  • 7. 
    This question refer to the article“Gliclazide Modified Release: Its place inthe therapeutic armamentarium”:Compliance and glycaemic control in type2 diabetic patients has been shown toimprove with which of the following?
    • A. 

      Twice daily dosing

    • B. 

      A high daily dose frequency

    • C. 

      Once daily dosing

    • D. 

      None of the above

  • 8. 
    This question refer to the article“Gliclazide Modified Release: Its place inthe therapeutic armamentarium”:Good glycaemic control can assist withwhich of the following? Choose all thatapply.[you must choose all the right ones to get a full mark]
    • A. 

      Primary prevention of microvascular complications

    • B. 

      Primary prevention of macrovascular complications

    • C. 

      Secondary prevention of microvascular complications

    • D. 

      Secondary prevention of macrovascular complicatIons

  • 9. 
    This question refer to the article “Areview of perindopril arginine and itsbenefits”:Which one of the following is not anindication of perindopril?
    • A. 

      Treatment of symptomatic heart failure

    • B. 

      Reduction of cardiac risk in patients with a history of myocardial infarction (MI) and/or coronary revascularisation

    • C. 

      Treatment of essential hypertension

    • D. 

      Treatment of unstable angina

  • 10. 
    This question refer to the article “Areview of perindopril arginine and itsbenefits”:Bioequivalence of the perindopril arginineand tert-butylamine salts has beendemonstrated with an area under theplasma concentration-time curve (AUCt)ratio of …
    • A. 

      93,6 % for perindopril

    • B. 

      100,0 % for perindoprilat

    • C. 

      98,2 % for perindopril

    • D. 

      None of the above

  • 11. 
    This question refer to the article “Areview of perindopril arginine and itsbenefits”:Perindopril arginine and perindopril-tertbutylaminecan be considered equivalentand interchangable.
    • A. 

      True

    • B. 

      False

  • 12. 
    This question refer to the article“Bedtime dosing of nifedipine GITS inhypertensive patients”:The main steps in the mechanismsregulating blood pressure (BP) arecircadian-stage-dependent.
    • A. 

      True

    • B. 

      False

  • 13. 
    This question refer to the article“Bedtime dosing of nifedipine GITS inhypertensive patients”:The patients in the trial were given a doseof nifedipine of:
    • A. 

      20 mg/day

    • B. 

      30 mg/day

    • C. 

      60 mg/day

    • D. 

      None of the above

  • 14. 
    This question refer to the article“Bedtime dosing of nifedipine GITS inhypertensive patients”:After 8 weeks of treatment the proportionof patients with a nondipper BP pattern:
    • A. 

      Decreased in the group given nifedipine on awakening

    • B. 

      Increased in the group given nifedipine on awakening

    • C. 

      Increased in the group given nifedipine at bedtime

    • D. 

      Decreased in the group given nifedipine at bedtime

  • 15. 
    This question refer to the article“Bedtime dosing of nifedipine GITS inhypertensive patients”:Night time dosing of nifedipine was shownto reduce the total incidence of oedemafrom: 
    • A. 

      13,4 % to 1,0 %

    • B. 

      17,5 % to 4,0 %

    • C. 

      13,5 % to 4,0 %

    • D. 

      17,4 % to 1,0 %

Related Topics
Back to Top Back to top